http://purl.uniprot.org/citations/22592212 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
http://purl.uniprot.org/citations/22592212 | http://www.w3.org/2000/01/rdf-schema#comment | "IntroductionThe three major clinically relevant mechanisms of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant lung cancer are a second mutation in the EGFR gene (T790M), Met amplification, and increased expression of hepatocyte growth factor (HGF). Heat shock protein90 (Hsp90) is a 90 kDa molecular chaperone for proteins that include EGFR, Met, and echinoderm microtubule-associated proetin-like-4-the anaplastic lymphoma kinase. Here, we determined whether inhibition of Hsp90 could overcome HGF-triggered EGFR-TKI resistance in EGFR mutant lung cancer cells.MethodsThe effects of the Hsp90 inhibitor 17-demethoxygeldanamycin (17-DMAG) on the growth of lung cancer cells resistant to the EGFR-TKI were examined in the presence and absence of HGF, and in cells transfected with the HGF gene in vitro and in vivo.ResultsEGFR-TKI erlotinib did not inhibit the growth of HGF-gene transfected Ma-1 (Ma-1/HGF) cells and H1975 cells, containing the EGFR L858R and T790M mutations, respectively. Erlotinib also did not inhibit the growth of PC-9 and Ma-1 cells, with deletions in EGFR exon19, in the presence of HGF. However, 17-DMAG induced apoptosis and markedly inhibited the growth of these cell lines, even in the presence of HGF. This inhibition by 17-DMAG was associated with decreased expression of EGFR and Met in tumor cells. An in vivo model of HGF-triggered erlotinib-resistance, which used Ma-1/HGF cells, showed that 17-DMAG markedly suppressed tumor growth by decreasing angiogenesis and increasing apoptosis.ConclusionsHsp90 inhibitors may overcome HGF-triggered resistance to EGFR-TKIs and may result in more successful treatment of patients with EGFR-mutant lung cancers."xsd:string |
http://purl.uniprot.org/citations/22592212 | http://purl.org/dc/terms/identifier | "doi:10.1097/jto.0b013e3182519a2c"xsd:string |
http://purl.uniprot.org/citations/22592212 | http://purl.uniprot.org/core/author | "Nakamura T."xsd:string |
http://purl.uniprot.org/citations/22592212 | http://purl.uniprot.org/core/author | "Matsumoto K."xsd:string |
http://purl.uniprot.org/citations/22592212 | http://purl.uniprot.org/core/author | "Nakagawa T."xsd:string |
http://purl.uniprot.org/citations/22592212 | http://purl.uniprot.org/core/author | "Yamada T."xsd:string |
http://purl.uniprot.org/citations/22592212 | http://purl.uniprot.org/core/author | "Kita K."xsd:string |
http://purl.uniprot.org/citations/22592212 | http://purl.uniprot.org/core/author | "Yano S."xsd:string |
http://purl.uniprot.org/citations/22592212 | http://purl.uniprot.org/core/author | "Koizumi H."xsd:string |
http://purl.uniprot.org/citations/22592212 | http://purl.uniprot.org/core/author | "Takeuchi S."xsd:string |
http://purl.uniprot.org/citations/22592212 | http://purl.uniprot.org/core/author | "Suda K."xsd:string |
http://purl.uniprot.org/citations/22592212 | http://purl.uniprot.org/core/author | "Mitsudomi T."xsd:string |
http://purl.uniprot.org/citations/22592212 | http://purl.uniprot.org/core/date | "2012"xsd:gYear |
http://purl.uniprot.org/citations/22592212 | http://purl.uniprot.org/core/name | "J Thorac Oncol"xsd:string |
http://purl.uniprot.org/citations/22592212 | http://purl.uniprot.org/core/pages | "1078-1085"xsd:string |
http://purl.uniprot.org/citations/22592212 | http://purl.uniprot.org/core/title | "Hsp90 inhibition overcomes HGF-triggering resistance to EGFR-TKIs in EGFR-mutant lung cancer by decreasing client protein expression and angiogenesis."xsd:string |
http://purl.uniprot.org/citations/22592212 | http://purl.uniprot.org/core/volume | "7"xsd:string |
http://purl.uniprot.org/citations/22592212 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/22592212 |
http://purl.uniprot.org/citations/22592212 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/22592212 |
http://purl.uniprot.org/uniprot/#_B4DTA5-mappedCitation-22592212 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/22592212 |
http://purl.uniprot.org/uniprot/#_K9JA46-mappedCitation-22592212 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/22592212 |
http://purl.uniprot.org/uniprot/#_Q2VPJ6-mappedCitation-22592212 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/22592212 |
http://purl.uniprot.org/uniprot/#_Q86U12-mappedCitation-22592212 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/22592212 |
http://purl.uniprot.org/uniprot/#_Q86SX1-mappedCitation-22592212 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/22592212 |